A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid Tumors
Conditions: Neoplasm Malignant Interventions: Biological: STRO-002 Sponsors: Tasly Pharmaceutical Group Co., Ltd; Sutro Biopharma, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | China Health | Epithelial Cancer | Ovarian Cancer | Ovaries | Research | Study